CDPQ divests 0.89% stake in Piramal Pharma via open market transaction

SmallCap World Fund Inc sold 7,08,978 shares, amounting to a 0.90 per cent stake in Aavas Financiers Ltd, as per the data available with the NSE

Piramal Pharma
Photo: Twitter
Press Trust of India New Delhi
2 min read Last Updated : Jun 16 2023 | 11:01 PM IST

CDPQ on Friday divested a 0.89 per cent stake in Piramal Pharma Ltd for Rs 100 crore through an open market transaction.

Caisse De Depot Et Placement Du Quebec (CDPQ) is a global investment group.

According to the bulk deal data available with the National Stock Exchange (NSE), CDPQ offloaded a total of 1,05,70,466 shares, amounting to a 0.89 per cent stake in Piramal Pharma.

The shares were sold at an average price of Rs 94.48 apiece, taking the transaction size to Rs 99.86 crore.

Post the latest transaction, CDPQ's shareholding has been reduced to 4.64 per cent from 5.53 per cent at March-end.

Meanwhile, Vanguard Group acquired more than 62 lakh shares of Piramal Pharma at an average price of Rs 94.71 per share, while other buyer(s) identity is not known.

Shares of Piramal Pharma went up 3.04 per cent to close at Rs 94.95 per piece on the NSE.

In a separate bulk deal, SmallCap World Fund Inc offloaded more than 7 lakh shares of Aavas Financiers for nearly Rs 96 crore through an open market transaction.

SmallCap World Fund Inc sold 7,08,978 shares, amounting to a 0.90 per cent stake in Aavas Financiers Ltd, as per the data available with the NSE.

Shares were disposed of at an average price of Rs 1,350.02 apiece, taking the deal value to Rs 95.71 crore.

Details of the buyers could not be ascertained.

On Friday, shares of Aavas Financiers gained 0.98 per cent to settle at Rs 1,353.70 apiece on the NSE.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PiramalCDPQStake sale

First Published: Jun 16 2023 | 11:01 PM IST

Next Story